Literature DB >> 14672279

The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia.

C Lin1, S T Wang, C W Wu, L J Chuo, Y M Kuo.   

Abstract

A polymorphism in the cystatin C (CST3) gene was suggested to associate with Alzheimer's disease (AD). In the present study we attempted to determine the association between CST3 polymorphism and AD or vascular dementia (VD), and whether such effects are dependent of the APOE4 allele. The polymorphisms of CST3 genotype were determined using polymerase chain reactions (PCR) followed by gel electrophoresis in 124 AD, 70 VD, and 115 control individuals. No statistical difference in CST3B allele frequencies was observed among all three groups. Associations between CST3B/B genotype and AD patients older than 75-year-old, or VD patients younger than 75-year-old were evident. The APOE4 allele alone significantly increased the odds for the developing AD, but not VD. A logistic regression analysis revealed that either CST3 or its interaction with APOE4 were not significant predictors of AD. However, a synergistic association of CST3 and APOE4 alleles was observed in predicting VD patients. These results suggest that CST3 might interact with APOE4 on conferring vascular pathologies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14672279

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  8 in total

Review 1.  Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies.

Authors:  Manjula Kurella Tamura; Kristine Yaffe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

2.  Regulation of cysteine cathepsin expression by oxidative stress in the retinal pigment epithelium/choroid of the mouse.

Authors:  Parvaneh Alizadeh; Zeljka Smit-McBride; Sharon L Oltjen; Leonard M Hjelmeland
Journal:  Exp Eye Res       Date:  2006-05-08       Impact factor: 3.467

3.  Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes.

Authors:  Chantel D Sloan; Li Shen; John D West; Heather A Wishart; Laura A Flashman; Laura A Rabin; Robert B Santulli; Stephen J Guerin; C Harker Rhodes; Gregory J Tsongalis; Thomas W McAllister; Tim A Ahles; Stephen L Lee; Jason H Moore; Andrew J Saykin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

Review 4.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

5.  Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways.

Authors:  Paolo Olgiati; Antonis M Politis; George N Papadimitriou; Diana De Ronchi; Alessandro Serretti
Journal:  Int J Alzheimers Dis       Date:  2011-12-10

6.  Cystatin C in Alzheimer's disease.

Authors:  Gurjinder Kaur; Efrat Levy
Journal:  Front Mol Neurosci       Date:  2012-07-06       Impact factor: 5.639

7.  Investigating APOE, APP-Aβ metabolism genes and Alzheimer's disease GWAS hits in brain small vessel ischemic disease.

Authors:  Sonja Blumenau; Marco Foddis; Susanne Müller; Manuel Holtgrewe; Kajetan Bentele; Daniel Berchtold; Dieter Beule; Ulrich Dirnagl; Celeste Sassi
Journal:  Sci Rep       Date:  2020-04-28       Impact factor: 4.379

8.  Deficiency in Lyst function leads to accumulation of secreted proteases and reduced retinal adhesion.

Authors:  Xiaojie Ji; Lihong Zhao; Ankita Umapathy; Bernard Fitzmaurice; Jieping Wang; David S Williams; Bo Chang; Jürgen K Naggert; Patsy M Nishina
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.